Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 13/2016

01-12-2016 | Original Article

Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging

Authors: Jason M. Williams, Lori R. Arlinghaus, Sudheer D. Rani, Martha D. Shone, Vandana G. Abramson, Praveen Pendyala, A. Bapsi Chakravarthy, William J. Gorge, Joshua G. Knowland, Ronald K. Lattanze, Steven R. Perrin, Charles W. Scarantino, David W. Townsend, Richard G. Abramson, Thomas E. Yankeelov

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 13/2016

Login to get access

Abstract

Purpose

To dynamically detect and characterize 18F-fluorodeoxyglucose (FDG) dose infiltrations and evaluate their effects on positron emission tomography (PET) standardized uptake values (SUV) at the injection site and in control tissue.

Methods

Investigational gamma scintillation sensors were topically applied to patients with locally advanced breast cancer scheduled to undergo limited whole-body FDG-PET as part of an ongoing clinical study. Relative to the affected breast, sensors were placed on the contralateral injection arm and ipsilateral control arm during the resting uptake phase prior to each patient’s PET scan. Time-activity curves (TACs) from the sensors were integrated at varying intervals (0–10, 0–20, 0–30, 0–40, and 30–40 min) post-FDG and the resulting areas under the curve (AUCs) were compared to SUVs obtained from PET.

Results

In cases of infiltration, observed in three sensor recordings (30 %), the injection arm TAC shape varied depending on the extent and severity of infiltration. In two of these cases, TAC characteristics suggested the infiltration was partially resolving prior to image acquisition, although it was still apparent on subsequent PET. Areas under the TAC 0–10 and 0–20 min post-FDG were significantly different in infiltrated versus non-infiltrated cases (Mann–Whitney, p < 0.05). When normalized to control, all TAC integration intervals from the injection arm were significantly correlated with SUVpeak and SUVmax measured over the infiltration site (Spearman ρ ≥ 0.77, p < 0.05). Receiver operating characteristic (ROC) analyses, testing the ability of the first 10 min of post-FDG sensor data to predict infiltration visibility on the ensuing PET, yielded an area under the ROC curve of 0.92.

Conclusions

Topical sensors applied near the injection site provide dynamic information from the time of FDG administration through the uptake period and may be useful in detecting infiltrations regardless of PET image field of view. This dynamic information may also complement the static PET image to better characterize the true extent of infiltrations.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hall NC, Zhang J, Reid R, Hurley D, Knopp MV. Impact of FDG extravasation on SUV measurements in clinical PET/CT. Should we routinely scan the injection site? J Nucl Med. 2006;47(Supplement 1):115P. Hall NC, Zhang J, Reid R, Hurley D, Knopp MV. Impact of FDG extravasation on SUV measurements in clinical PET/CT. Should we routinely scan the injection site? J Nucl Med. 2006;47(Supplement 1):115P.
5.
go back to reference Silva-Rodriguez J, Aguiar P, Sanchez M, Mosquera J, Luna-Vega V, Cortes J, et al. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies. Med Phys. 2014;41(5):052502. doi:10.1118/1.4870979.CrossRefPubMed Silva-Rodriguez J, Aguiar P, Sanchez M, Mosquera J, Luna-Vega V, Cortes J, et al. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies. Med Phys. 2014;41(5):052502. doi:10.​1118/​1.​4870979.CrossRefPubMed
6.
go back to reference Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47(5):885–95.PubMed Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47(5):885–95.PubMed
8.
go back to reference Knowland JG, Scarantino CW, Lattanze RK. System for the detection of gamma radiation from a radioactive analyte. Google Patents. 2013; US 20130324844 A1. Knowland JG, Scarantino CW, Lattanze RK. System for the detection of gamma radiation from a radioactive analyte. Google Patents. 2013; US 20130324844 A1.
9.
go back to reference Atuegwu NC, Li X, Arlinghaus LR, Abramson RG, Williams JM, Chakravarthy AB, et al. Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results. Med Phys. 2014;41(5):052302. doi:10.1118/1.4870966.CrossRefPubMedPubMedCentral Atuegwu NC, Li X, Arlinghaus LR, Abramson RG, Williams JM, Chakravarthy AB, et al. Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results. Med Phys. 2014;41(5):052302. doi:10.​1118/​1.​4870966.CrossRefPubMedPubMedCentral
10.
Metadata
Title
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging
Authors
Jason M. Williams
Lori R. Arlinghaus
Sudheer D. Rani
Martha D. Shone
Vandana G. Abramson
Praveen Pendyala
A. Bapsi Chakravarthy
William J. Gorge
Joshua G. Knowland
Ronald K. Lattanze
Steven R. Perrin
Charles W. Scarantino
David W. Townsend
Richard G. Abramson
Thomas E. Yankeelov
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 13/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3477-3

Other articles of this Issue 13/2016

European Journal of Nuclear Medicine and Molecular Imaging 13/2016 Go to the issue